Boundless Bio Files 8-K on Exit Costs and Other Events

Ticker: BOLD · Form: 8-K · Filed: May 23, 2025 · CIK: 1782303

Boundless Bio, INC. 8-K Filing Summary
FieldDetail
CompanyBoundless Bio, INC. (BOLD)
Form Type8-K
Filed DateMay 23, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disposal-activities, corporate-events

TL;DR

Boundless Bio filed an 8-K for exit costs and other events. Keep an eye on this.

AI Summary

On May 23, 2025, Boundless Bio, Inc. filed an 8-K report detailing cost associated with exit or disposal activities and other events. The company, incorporated in Delaware with its principal executive offices in San Diego, California, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates potential restructuring or divestiture activities within Boundless Bio, which could impact its future operations and financial standing.

Risk Assessment

Risk Level: medium — Filings related to exit or disposal activities can signal significant business changes that may carry inherent risks.

Key Numbers

Key Players & Entities

FAQ

What specific exit or disposal activities are being reported by Boundless Bio?

The filing does not specify the exact nature of the cost associated with exit or disposal activities, only that it is an item being reported.

What are the 'Other Events' mentioned in the filing?

The filing lists 'Other Events' as an item information category but does not provide specific details within the provided text.

When was Boundless Bio, Inc. incorporated?

Boundless Bio, Inc. was incorporated in Delaware.

What is the principal business address of Boundless Bio, Inc.?

The principal executive offices are located at 10955 Alexandria Way, Suite 100, San Diego, California 92121.

What is the SIC code for Boundless Bio, Inc.?

The Standard Industrial Classification code for Boundless Bio, Inc. is 2834, Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Boundless Bio, Inc. (BOLD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing